Nolato acquires Cope Allman Jaycare

Acquisition of British pharmaceutical packaging company
results in a stronger
customer base and geographic expansion for Nolato Medical
As part of the Nolato Group’s strategic expansion within medical technology and
pharmaceuticals, Nolato has acquired the British company Cope Allman Jaycare for
an initial purchase price of SEK 179 million (enterprise value) and a deferred
consideration based on earnings up to and including the first quarter of
2014.

Cope Allman Jaycare, which manufactures plastic pharmaceutical
packaging, has annual sales of around SEK 270 million. Its customers include a
number of major international pharmaceutical companies. The company will be
consolidated from 1 April, and will have a positive effect on Nolato’s earnings
per share 2012.

“Following the acquisition of the US company Contour
Plastics, we have worked to add an acquisition in Western Europe,” says Hans
Porat, President and CEO of Nolato. “Cope Allman Jaycare is a well-managed
company, and is a good fit for our growth strategy.”

Cope Allman Jaycare has
a history within pharmaceutical packaging dating back to 1958, and is expected
to record sales for 2012 of around SEK 270 million, with a pro forma EBITDA
margin of approximately 14%. The company has 270 employees at its plants in
Portsmouth and Newcastle, England.

“Nolato already has a strong position in
the Scandinavian pharmaceutical packaging market,” adds Christer Wahlquist,
President of Nolato Medical. “This acquisition gives us a local presence in the
UK, which is an important part of the global pharma­ceutical industry. It also
opens doors with a large number of leading international pharmaceutical
companies which are existing customers of Cope Allman Jaycare.”

The company
is being acquired from its current management, which will remain with the
business.

Following the acquisition, Nolato will continue to have a strong
financial position, with an equity/assets ratio of approximately 47%.

----
-

For further information, please contact:
Hans Porat, CEO, +46 431
442294
Per-Ola Holmström, CFO, +46 431 442293

The Nolato Group is a high
-tech developer and manufacturer of polymer product systems for leading
customers in medical technology, telecom, hygiene, automotive products and other
­selected industrial sectors. Nolato’s shares are quoted on the Nasdaq OMX
Nordic Exchange, Stockholm Mid Cap, Industrials.  www.nolato.com

Nolato AB
discloses the information provided herein pursuant to the Securities Markets Act
and/or the Financial Instruments Trading Act. The information was submitted for
publication at 8.25 am on 11 April 2012.